Role of phytochemicals in colorectal cancer prevention

World Journal of Gastroenterology

Volumn 21, Issue 31, 2015, Pages 9262-9272

  Li, Yu Hua ^a,b   Niu, Yin Bo ^c   Sun, Yang ^a   Zhang, Feng ^a   Liu, Chang Xu ^d   Fan, Lei ^a   Mei, Qi Bing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b No 181 Hospital of PLA   (China)

^c NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^d The 303rd Hospital of PLA   (China)

Author keywords

Cancer prevention; Colorectal cancer; Fruits; Phytochemicals; Spices; Vegetables

Indexed keywords

APPLE POLYSACCHARIDE; CURCUMIN; GINSENOSIDE; GLUCAN; MUSHROOM GLUCAN; NATURAL PRODUCT; PARIS SAPONIN; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE; QUERCETIN; RESVERATROL; SAPONIN; SOY SAPONIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

APPLE; ARTICLE; CANCER PREVENTION; CANCER THERAPY; CLINICAL TRIAL (TOPIC); COLORECTAL CANCER; DRUG MECHANISM; HUMAN; MEDICINAL MUSHROOM; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); ADVERSE EFFECTS; ANIMAL; COLORECTAL NEOPLASMS; DIET; FRUIT; RISK FACTOR; RISK REDUCTION; SPICE; VEGETABLE;

ANIMALS; ANTICARCINOGENIC AGENTS; COLORECTAL NEOPLASMS; DIET; FRUIT; HUMANS; PHYTOCHEMICALS; RISK FACTORS; RISK REDUCTION BEHAVIOR; SPICES; VEGETABLES;

EID: 84940093636     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i31.9262     Document Type: Article

References (91)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer. CA Cancer J Clin 2009; 59: 366-378 [PMID: 19897840 DOI: 10.3322/caac.20038]
3. Center MM, Jemal A, Ward E. International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev 2009; 18: 1688-1694 [PMID: 19505900 DOI: 10.1158/1055-9965. EPI-09-0090]
4. Wan DS. [Epidemiologic trend of and strategies for colorectal cancer]. Ai Zheng 2009; 28: 897-902 [PMID: 19728903]
5. Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol 2005; 23: 3706-3712 [PMID: 15867200 DOI: 10.1200/JCO.2005.00.232]
6. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004; 96: 1420-1425 [PMID: 15467030 DOI: 10.1093/jnci/djh275]
7. Anand P, Kunnumakkara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 2008; 25: 2097-2116 [PMID: 18626751 DOI: 10.1007/s11095-008-9661-9]
8. Sporn MB, Suh N. Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2002; 2: 537-543 [PMID: 12094240 DOI: 10.1038/nrc844]
9. Shukla S, Meeran SM, Katiyar SK. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention. Cancer Lett 2014; 355: 9-17 [PMID: 25236912 DOI: 10.1016/ j.canlet.2014.09.017]
10. Jaganathan SK, Vellayappan MV, Narasimhan G, Supriyanto E. Role of pomegranate and citrus fruit juices in colon cancer prevention. World J Gastroenterol 2014; 20: 4618-4625 [PMID: 24782614 DOI: 10.3748/wjg.v20.i16.4618]
11. Available from: URL: http://www.fda.gov/cder/drug/infopage/cox2/NSAIDdecision Memo
12. Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci R. Diet and cancer. Acta Biomed 2006; 77: 118-123 [PMID: 17172193]
13. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996; 96: 1027-1039 [PMID: 8841165 DOI: 10.1016/S0002-8223(96)00273-8]
14. Greenwald P. Lifestyle and medical approaches to cancer prevention. Recent Results Cancer Res 2005; 166: 1-15 [PMID: 15648179]
15. Vainio H, Weiderpass E. Fruit and vegetables in cancer prevention. Nutr Cancer 2006; 54: 111-142 [PMID: 16800779 DOI: 10.1207/s15327914nc5401-13]
16. Temraz S, Mukherji D, Shamseddine A. Potential targets for colorectal cancer prevention. Int J Mol Sci 2013; 14: 17279-17303 [PMID: 23975167 DOI: 10.3390/ijms140917279]
17. He ZY, Shi CB, Wen H, Li FL, Wang BL, Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest 2011; 29: 208-213 [PMID: 21314329 DOI: 10.3109/07357907.2010.550592]
18. Guo LD, Chen XJ, Hu YH, Yu ZJ, Wang D, Liu JZ. Curcumin inhibits proliferation and induces apoptosis of human colorectal cancer cells by activating the mitochondria apoptotic pathway. Phytother Res 2013; 27: 422-430 [PMID: 22628241 DOI: 10.1002/ptr.4731]
19. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444 [PMID: 18650914 DOI: 10.1038/nature07205]
20. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 2004; 6: 297-305 [PMID: 15380520 DOI: 10.1016/j.ccr.2004.08.012]
21. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296 [PMID: 15294155 DOI: 10.1016/ j.cell.2004.07.013]
22. Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann N Y Acad Sci 2005; 1056: 206-217 [PMID: 16387689 DOI: 10.1196/annals.1352.010]
23. Singh S, Aggarwal BB. Activation of transcription factor NFkappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 1995; 270: 24995-25000 [PMID: 7559628]
24. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188 [PMID: 7926468]
25. Elder DJ, Baker JA, Banu NA, Moorghen M, Paraskeva C. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. J Pathol 2002; 198: 428-434 [PMID: 12434411 DOI: 10.1002/path.1232]
26. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995; 55: 2556-2559 [PMID: 7780968]
27. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M, Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-3789 [PMID: 7641194]
28. Sheehan KM, Sheahan K, O'Donoghue DP, MacSweeney F, Conroy RM, Fitzgerald DJ, Murray FE. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 1999; 282: 1254-1257 [PMID: 10517428 DOI: 10.1001/jama.282.13.1254]
29. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87: 803-809 [PMID: 8945508 DOI: 10.1016/S0092-8674(00)81988-1]
30. Jacoby RF, Seibert K, Cole CE, Kelloff G, Lubet RA. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 2000; 60: 5040-5044 [PMID: 11016626]
31. Lev-Ari S, Strier L, Kazanov D, Madar-Shapiro L, Dvory-Sobol H, Pinchuk I, Marian B, Lichtenberg D, Arber N. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res 2005; 11: 6738-6744 [PMID: 16166455 DOI: 10.1158/1078-0432.CCR-05-0171]
32. Radhakrishnan VM, Kojs P, Young G, Ramalingam R, Jagadish B, Mash EA, Martinez JD, Ghishan FK, Kiela PR. pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1). PLoS One 2014; 9: e85796 [PMID: 24465712 DOI: 10.1371/journal.pone.0085796]
33. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004; 10: 6847-6854 [PMID: 15501961 DOI: 10.1158/1078-0432.CCR-04-0744]
34. Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001; 7: 1894-1900 [PMID: 11448902]
35. Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 2005; 14: 120-125 [PMID: 15668484]
36. Carroll RE, Benya RV, Turgeon DK, Vareed S, Neuman M, Rodriguez L, Kakarala M, Carpenter PM, McLaren C, Meyskens FL, Brenner DE. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila) 2011; 4: 354-364 [PMID: 21372035 DOI: 10.1158/1940-6207.CAPR-10-0098]
37. Jedrychowski W, Maugeri U. An apple a day may hold colorectal cancer at bay: recent evidence from a case-control study. Rev Environ Health 2009; 24: 59-74 [PMID: 19476292]
38. Barth SW, Fähndrich C, Bub A, Dietrich H, Watzl B, Will F, Briviba K, Rechkemmer G. Cloudy apple juice decreases DNA damage, hyperproliferation and aberrant crypt foci development in the distal colon of DMH-initiated rats. Carcinogenesis 2005; 26: 1414-1421 [PMID: 15802299 DOI: 10.1093/carcin/bgi082]
39. Li Y, Mei L, Niu Y, Sun Y, Huang H, Li Q, Kong X, Liu L, Li Z, Mei Q. Low molecular weight apple polysaccharides induced cell cycle arrest in colorectal tumor. Nutr Cancer 2012; 64: 439-463 [PMID: 22429028 DOI: 10.1080/01635581.2012.658951]
40. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu FT, Iacobelli S. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol 2002; 23: 313-320 [PMID: 12072371 DOI: 10.1016/S1471-4906(02)02232-9]
41. Rubinstein N, Ilarregui JM, Toscano MA, Rabinovich GA. The role of galectins in the initiation, amplification and resolution of the inflammatory response. Tissue Antigens 2004; 64: 1-12 [PMID: 15191517 DOI: 10.1111/j.1399-0039.2004.00278.x]
42. Liu FT, Hsu DK. The role of galectin-3 in promotion of the inflammatory response. Drug News Perspect 2007; 20: 455-460 [PMID: 17992268 DOI: 10.1358/dnp.2007.20.7.1149628]
43. Song YK, Billiar TR, Lee YJ. Role of galectin-3 in breast cancer metastasis: involvement of nitric oxide. Am J Pathol 2002; 160: 1069-1075 [PMID: 11891203 DOI: 10.1016/S0002-9440(10)64927-9]
44. Honjo Y, Nangia-Makker P, Inohara H, Raz A. Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells. Clin Cancer Res 2001; 7: 661-668 [PMID: 11297262]
45. Bresalier RS, Mazurek N, Sternberg LR, Byrd JC, Yunker CK, Nangia-Makker P, Raz A. Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology 1998; 115: 287-296 [PMID: 9679034 DOI: 10.1016/S0016-5085(98)70195-7]
46. Endo K, Kohnoe S, Tsujita E, Watanabe A, Nakashima H, Baba H, Maehara Y. Galectin-3 expression is a potent prognostic marker in colorectal cancer. Anticancer Res 2005; 25: 3117-3121 [PMID: 16080575]
47. Tsuboi K, Shimura T, Masuda N, Ide M, Tsutsumi S, Yamaguchi S, Asao T, Kuwano H. Galectin-3 expression in colorectal cancer: relation to invasion and metastasis. Anticancer Res 2007; 27: 2289-2296 [PMID: 17695516]
48. Li Y, Liu L, Niu Y, Feng J, Sun Y, Kong X, Chen Y, Chen X, Gan H, Cao S, Mei Q. Modified apple polysaccharide prevents against tumorigenesis in a mouse model of colitis-associated colon cancer: role of galectin-3 and apoptosis in cancer prevention. Eur J Nutr 2012; 51: 107-117 [PMID: 21516492 DOI: 10.1007/s00394-011-0194-3]
49. Pålsson-McDermott EM, O'Neill LA. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004; 113: 153-162 [PMID: 15379975 DOI: 10.1111/ j.1365-2567.2004.01976.x]
50. Bals R, Hiemstra PS. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J 2004; 23: 327-333 [PMID: 14979512 DOI: 10.1183/09031936.03.00098803]
51. Zhang D, Li YH, Mi M, Jiang FL, Yue ZG, Sun Y, Fan L, Meng J, Zhang X, Liu L, Mei QB. Modified apple polysaccharides suppress the migration and invasion of colorectal cancer cells induced by lipopolysaccharide. Nutr Res 2013; 33: 839-848 [PMID: 24074742 DOI: 10.1016/j.nutres.2013.06.004]
52. Lavi I, Nimri L, Levinson D, Peri I, Hadar Y, Schwartz B. Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitisassociated colon carcinogenesis in mice. J Gastroenterol 2012; 47: 504-518 [PMID: 22187166 DOI: 10.1007/s00535-011-0514-7]
53. Xie JT, Wang CZ, Wicks S, Yin JJ, Kong J, Li J, Li YC, Yuan CS. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells. Exp Oncol 2006; 28: 25-29 [PMID: 16614703]
54. Lavi I, Friesem D, Geresh S, Hadar Y, Schwartz B. An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells. Cancer Lett 2006; 244: 61-70 [PMID: 16413114 DOI: 10.1016/j.canlet.2005.12.007]
55. Shanmugam MK, Kannaiyan R, Sethi G. Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 2011; 63: 161-173 [PMID: 21294053 DOI: 10.1080/01635581.2011.523502]
56. Hu H, Zhang Z, Lei Z, Yang Y, Sugiura N. Comparative study of antioxidant activity and antiproliferative effect of hot water and ethanol extracts from the mushroom Inonotus obliquus. J Biosci Bioeng 2009; 107: 42-48 [PMID: 19147108 DOI: 10.1016/j.jbiosc.2008.09.004]
57. Hostettmann K, Marston A. Saponins. Cambridge: Cambridge University Press, 1995
58. Liener, Irvin E. Toxic constituents of plant foodstuffs. New York City: Academic Press, 1980
59. Available from: URL: http://sun.ars-grin.gov:8080/npgspub/xsql/duke/plantdisp.xsql?taxon=691
60. Ali R, Mirza Z, Ashraf GM, Kamal MA, Ansari SA, Damanhouri GA, Abuzenadah AM, Chaudhary AG, Sheikh IA. New anticancer agents: recent developments in tumor therapy. Anticancer Res 2012; 32: 2999-3005 [PMID: 22753764]
61. Li Y, Sun Y, Fan L, Zhang F, Meng J, Han J, Guo X, Zhang D, Zhang R, Yue Z, Mei Q. Paris saponin VII inhibits growth of colorectal cancer cells through Ras signaling pathway. Biochem Pharmacol 2014; 88: 150-157 [PMID: 24462916 DOI: 10.1016/j.bcp.2014.01.018]
62. Kennedy DO, Scholey AB. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav 2003; 75: 687-700 [PMID: 12895687 DOI: 10.1016/S0091-3057(03)00126-6]
63. Yun TK. Experimental and epidemiological evidence on nonorgan specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 2003; 523-524: 63-74 [PMID: 12628504 DOI: 10.1016/S0027-5107(02)00322-6]
64. Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 1995; 4: 401-408 [PMID: 7655337]
65. Yun TK, Choi SY, Yun HY. Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng? J Korean Med Sci 2001; 16 Suppl: S19-S27 [PMID: 11748373]
66. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 2004; 27: 429-435 [PMID: 15180309 DOI: 10.1007/BF02980085]
67. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004; 9: 259-274 [PMID: 15387718]
68. Liu TG, Huang Y, Cui DD, Huang XB, Mao SH, Ji LL, Song HB, Yi C. Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice. BMC Cancer 2009; 9: 250 [PMID: 19624862 DOI: 10.1186/1471-2407-9-250]
69. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett 2011; 301: 185-192 [PMID: 21194832 DOI: 10.1016/j.canlet.2010.11.015]
70. He BC, Gao JL, Luo X, Luo J, Shen J, Wang L, Zhou Q, Wang YT, Luu HH, Haydon RC, Wang CZ, Du W, Yuan CS, He TC, Zhang BQ. Ginsenoside Rg3 inhibits colorectal tumor growth through the down-regulation of Wnt/β-catenin signaling. Int J Oncol 2011; 38: 437-445 [PMID: 21152855 DOI: 10.3892/ijo.2010.858]
71. Yuan HD, Quan HY, Zhang Y, Kim SH, Chung SH. 20(S)-Ginsenoside Rg3-induced apoptosis in HT-29 colon cancer cells is associated with AMPK signaling pathway. Mol Med Rep 2010; 3: 825-831 [PMID: 21472321 DOI: 10.3892/mmr.2010.328]
72. Qi LW, Wang CZ, Yuan CS. American ginseng: potential structurefunction relationship in cancer chemoprevention. Biochem Pharmacol 2010; 80: 947-954 [PMID: 20599804 DOI: 10.1016/ j.bcp.2010.06.023]
73. Park JW, Lee JC, Ann S, Seo DW, Choi WS, Yoo YH, Park SK, Choi JY, Um SH, Ahn SH, Han JW. A fermented ginseng extract, BST204, inhibits proliferation and motility of human colon cancer cells. Biomolecules and Therapeutics 2011; 19: 211-217 [DOI: 10.4062/biomolther.2011.19.2.211]
74. Kim HY, Yu R, Kim JS, Kim YK, Sung MK. Antiproliferative crude soy saponin extract modulates the expression of IkappaBalpha, protein kinase C, and cyclooxygenase-2 in human colon cancer cells. Cancer Lett 2004; 210: 1-6 [PMID: 15172114 DOI: 10.1016/j.canlet.2004.01.009]
75. Tsai CY, Chen YH, Chien YW, Huang WH, Lin SH. Effect of soy saponin on the growth of human colon cancer cells. World J Gastroenterol 2010; 16: 3371-3376 [PMID: 20632438 DOI: 10.3748/wjg.v16.i27.3371]
76. Panaro MA, Carofiglio V, Acquafredda A, Cavallo P, Cianciulli A. Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-êB activation in Caco-2 and SW480 human colon cancer cells. Br J Nutr 2012; 108: 1623-1632 [PMID: 22251620 DOI: 10.1017/S0007114511007227]
77. Serra D, Rufino AT, Mendes AF, Almeida LM, Dinis TC. Resveratrol modulates cytokine-induced Jak/STAT activation more efficiently than 5-aminosalicylic acid: an in vitro approach. PLoS One 2014; 9: e109048 [PMID: 25271420 DOI: 10.1371/journal.pone.0109048]
78. Liu YZ, Wu K, Huang J, Liu Y, Wang X, Meng ZJ, Yuan SX, Wang DX, Luo JY, Zuo GW, Yin LJ, Chen L, Deng ZL, Yang JQ, Sun WJ, He BC. The PTEN/PI3K/Akt and Wnt/β-catenin signaling pathways are involved in the inhibitory effect of resveratrol on human colon cancer cell proliferation. Int J Oncol 2014; 45: 104-112 [PMID: 24756222 DOI: 10.3892/ijo.2014.2392]
79. Fouad MA, Agha AM, Merzabani MM, Shouman SA. Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells: calorie restriction is the force to the cytotoxicity. Hum Exp Toxicol 2013; 32: 1067-1080 [PMID: 23536519 DOI: 10.1177/0960327113475679]
80. Miki H, Uehara N, Kimura A, Sasaki T, Yuri T, Yoshizawa K, Tsubura A. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol 2012; 40: 1020-1028 [PMID: 22218562 DOI: 10.3892/ijo.2012.1325]
81. Tessitore L, Davit A, Sarotto I, Caderni G. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 2000; 21: 1619-1622 [PMID: 10910967 DOI: 10.1093/carcin/21.8.1619]
82. Sengottuvelan M, Nalini N. Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazinetreated rats by modulating biotransforming enzymes and aberrant crypt foci development. Br J Nutr 2006; 96: 145-153 [PMID: 16870003 DOI: 10.1079/BJN20061789]
83. Sengottuvelan M, Deeptha K, Nalini N. Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazine-induced colon carcinogenesis. Nutrition 2009; 25: 1169-1176 [PMID: 19818280 DOI: 10.1016/j.nut.2009.03.009]
84. Saud SM, Li W, Morris NL, Matter MS, Colburn NH, Kim YS, Young MR. Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression. Carcinogenesis 2014; 35: 2778-2786 [PMID: 25280562 DOI: 10.1093/carcin/bgu209]
85. Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 2010; 70: 7392-7399 [PMID: 20841478 DOI: 10.1158/0008-5472. CAN-10-2027]
86. Priego S, Feddi F, Ferrer P, Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, Asensi M, Estrela JM. Natural polyphenols facilitate elimination of HT-29 colorectal cancer xenografts by chemoradiotherapy: a Bcl-2- and superoxide dismutase 2-dependent mechanism. Mol Cancer Ther 2008; 7: 3330-3342 [PMID: 18852136 DOI: 10.1158/1535-7163.MCT-08-0363]
87. Fridrich D, Teller N, Esselen M, Pahlke G, Marko D. Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation. Mol Nutr Food Res 2008; 52: 815-822 [PMID: 18618485 DOI: 10.1002/mnfr.200800026]
88. Mutoh M, Takahashi M, Fukuda K, Komatsu H, Enya T, Matsushima-Hibiya Y, Mutoh H, Sugimura T, Wakabayashi K. Suppression by flavonoids of cyclooxygenase-2 promoterdependent transcriptional activity in colon cancer cells: structureactivity relationship. Jpn J Cancer Res 2000; 91: 686-691 [PMID: 10920275]
89. Park CH, Chang JY, Hahm ER, Park S, Kim HK, Yang CH. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells. Biochem Biophys Res Commun 2005; 328: 227-234 [PMID: 15670774 DOI: 10.1016/j.bbrc.2004.12.151]
90. Shan BE, Wang MX, Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 2009; 27: 604-612 [PMID: 19440933 DOI: 10.1080/ 07357900802337191]
91. Kim HJ, Kim SK, Kim BS, Lee SH, Park YS, Park BK, Kim SJ, Kim J, Choi C, Kim JS, Cho SD, Jung JW, Roh KH, Kang KS, Jung JY. Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J Agric Food Chem 2010; 58: 8643-8650 [PMID: 20681654 DOI: 10.1021/jf101510z]